[{"from": "human", "value": "Provide a description of this molecule. [C][C][N][C][=C][Branch1][=C][C][=Branch1][C][=O][N][Branch1][Branch1][C][Ring1][#Branch1][=O][C][C][N][Branch2][Ring1][=Branch2][C][=Branch1][Ring2][=N][Ring1][N][/C][=C][/C][=C][C][=Branch1][#Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][O][C][C]"}, {"from": "gpt", "value": "The molecule is highly involved in motor control.  Istradefylline is indicated as an adjunct treatment to [levodopa] and [carbidopa] for Parkinson's disease.  This drug was first approved in Japan on 25 March 2013. Istradefylline was granted FDA approval on 27 August 2019."}]